Coronavirus Update: Vertex, Pfizer And Others Disclose Trial Disruptions, Viatris Merger Delayed

Clinical trials in a range of diseases continue to be impacted by concerns about patient safety and health care resources as the COVID-19 pandemic grows.

Coronavirus mask
Coronavirus-Related Concerns Are Pausing Some Drug Trials • Source: Shutterstock

The pace of biopharmaceutical company announcements about COVID-19 concerns impacting clinical trials and other areas of their business is picking up. At least seven companies made such disclosures on 26 and 27 March, including Vertex Pharmaceuticals Inc.

Vertex said the supply chain for its cystic fibrosis medications is holding steady and it anticipates no problems getting drugs...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip